Skip to main content
. 2024 Jul 5;85(3):e101–e111. doi: 10.1055/s-0044-1788310

Table 1. Cases of sinonasal malignancy following cranial irradiation for brain tumor ( n  = 14) .

Case # Author, Year Age (y) a Gender Primary cancer Primary cancer treatment Primary cancer radiation dose Latency period b (y) Secondary sinonasal cancer Secondary cancer treatment Outcome
1 Goyal et al, 2015 17 M Glioblastoma multiforme Radiotherapy, chemotherapy 50.4 Gy, 28 fractions 1.5 Round cell carcinoma (undifferentiated) Died after four cycles of chemotherapy Rapid growth; died after 3 months
2 Ito et al, 2010 40 F Frontal glioma (low-grade) Resection, radiotherapy, chemotherapy 54 Gy, 27 fractions 16 Osteosarcoma Died prior to planned resection Rapid growth; died
3 Ito et al, 2010 46 M Bifrontal anaplastic oligoastrocytoma Resection, radiotherapy, chemotherapy 56 Gy, 28 fractions 12 Osteosarcoma Died during radiotherapy treatment Rapid growth; died
4 Park et al, 2008 39 F Pituitary adenoma (prolactinoma) Resection, radiotherapy 54 Gy, 30 fractions 20 Olfactory neuroblastoma Resection, chemotherapy Survived
5 Perez Garcia et al, 2011 43 F Bifrontal astrocytoma (low-grade) Radiotherapy 58 Gy, 5 fractions per week (holocranial 40 Gy, frontal 18 Gy) 9 Olfactory neuroblastoma Resection, radiotherapy, chemotherapy Recurrent twice; died after 13 months
6 Wallin et al, 2007 2.5 M Medulloblastoma and parietal meningioma Radiotherapy (medulloblastoma), resection (parietal meningioma) 45 Gy (23.4 Gy spine, 21.6 Gy posterior fossa) 16.5 Neuroendocrine carcinoma (poorly differentiated) Resection Survived
7 Kakkar et al, 2019 36 F Frontal diffuse astrocytoma Resection, radiotherapy 56 Gy, 28 fractions 5.5 Papillary adenocarcinoma Resection No disease evident at 8 months
8 Patel et al, 2017 54 M Anaplastic oligoastrocytoma Resection, radiotherapy, chemotherapy NS 16 Carcinosarcoma Resection, Cesium-131 brachytherapy No disease evident at 9 months
9 Nery et al, 2022 48 M Pituitary macroadenoma Resection, radiotherapy NS 12 Mucoepidermoid carcinoma Resection, radiotherapy, chemotherapy Survived
10 Sahoo et al, 2022 12 M Medulloblastoma Resection, radiotherapy, chemotherapy 56 Gy, 30 fractions 2 Olfactory neuroblastoma Resection Died after 8 months
11 Christopherson et al, 2014 7.1 c NS Medulloblastoma Resection, radiotherapy, chemotherapy 54 Gy (craniospinal 28.8 Gy) d 6.4 Rhabdomyosarcoma Radiotherapy, chemotherapy Treatment successful; last follow-up unknown
12 Packer et al, 2013 6.8 c NS Medulloblastoma Resection, radiotherapy, chemotherapy 55.8 Gy (23.4 Gy craniospinal, 32.4 Gy posterior fossa) 4.8 Spindle cell carcinoma Unknown Survived at least 1.67 years
13 Delank and Ballantyne, 1993 68 M Pituitary adenoma (prolactinoma) Resection, radiotherapy, chemotherapy 1.8 Gy 6.5 Malignant melanoma Resection, radiotherapy Died after 1.5 years
14 Delank and Ballantyne, 1993 65 M Pituitary adenoma Resection, radiotherapy 3.0 Gy 10 Olfactory neuroblastoma Radiotherapy, chemotherapy Died after 9 months

Abbreviations: F, female; Gy, gray (unit); M, male; NS, not specified.

a

Age at diagnosis of brain tumor.

b

Time between irradiation of the brain tumor and diagnosis of the secondary sinonasal malignancy.

c

Median age of study participants; participant-specific ages not specified.

d

Median dose administered to study participants; participant-specific doses not specified.